» Articles » PMID: 27778204

Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2016 Oct 26
PMID 27778204
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The utility of postoperative medical prophylaxis (POMP) and the treatment of mild endoscopic recurrence remain controversial.

Methods: This study is a retrospective review of patients undergoing a primary ileocolic resection for CD at a single academic center. Endoscopic recurrence (ER) was defined using the Rutgeerts score (RS), and clinical recurrence (CR) was defined as symptoms of CD with endoscopic or radiologic evidence of neo-terminal ileal disease.

Results: There were 171 patients who met inclusion criteria. The cumulative probability of ER (RS ≥ i-1) at 1, 2, and 5 years was 29, 51, and 77 %, respectively. The only independent predictors of ER were the absence of POMP (HR 1.50; P = 0.03) and penetrating disease behavior (HR 1.50; P = 0.05). The cumulative probability of CR at 1, 2, and 5 years was 8, 13, and 27 %, respectively. There was a higher rate of clinical recurrence in patients with RS-2 compared to RS-1 on the initial postoperative endoscopy (HR 2.50; P = 0.02). In 11 patients not exposed to POMP with i-1 on initial endoscopy, only 2 patients (18 %) progressed endoscopically during the study period while 5 patients (45 %) regressed to i-0 on subsequent endoscopy without treatment.

Conclusions: Postoperative medical prophylaxis decreased the likelihood of ER while certain phenotypes of CD appear to increase the risk of developing ER and CR. There may be a role for watchful waiting in patients with mild endoscopic recurrence on the initial postoperative endoscopy.

Citing Articles

Small bowel pyloric metaplasia is associated with lower rates of earlier recurrence of Crohn's disease after resection.

Ju J, Escobar D, Xue Y, Booth A, Nguyen J, Yang G Hum Pathol. 2024; 151:105629.

PMID: 39029533 PMC: 11617028. DOI: 10.1016/j.humpath.2024.105629.


How Reliable Is Endoscopic Scoring of Postoperative Recurrence in Crohn Disease?: A Systematic Review and Meta-Analysis.

van der Does de Willebois E, Bellato V, Duijvestein M, van Dieren S, Danese S, Sileri P Ann Surg Open. 2024; 5(1):e397.

PMID: 38883962 PMC: 11175939. DOI: 10.1097/AS9.0000000000000397.


Perforating and nonperforating indications in repeated surgeries for Crohn's disease.

Shen W, Huang X, Liu R, Li C, Li Y, Zhu W World J Clin Cases. 2022; 10(9):2733-2742.

PMID: 35434111 PMC: 8968811. DOI: 10.12998/wjcc.v10.i9.2733.


Predictors of postoperative recurrence in a cohort of Tunisian patients with Crohn's disease.

Hammami A, Harbi R, Elleuch N, Meddeb K, Ben Ameur W, Dahmani W Ther Adv Gastrointest Endosc. 2022; 15:26317745211060689.

PMID: 35321255 PMC: 8935554. DOI: 10.1177/26317745211060689.


The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn's Disease: A Systematic Review and Meta-analysis.

Ble A, Renzulli C, Cenci F, Grimaldi M, Barone M, Sedano R J Crohns Colitis. 2021; 16(3):490-499.

PMID: 34508572 PMC: 8919832. DOI: 10.1093/ecco-jcc/jjab163.


References
1.
Waterman M, Xu W, Stempak J, Milgrom R, Bernstein C, Griffiths A . Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011; 17(9):1936-42. PMC: 3164287. DOI: 10.1002/ibd.21579. View

2.
Tursi A, Elisei W, Picchio M, Zampaletta C, Pelecca G, Faggiani R . Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study. Tech Coloproctol. 2014; 18(11):1041-6. DOI: 10.1007/s10151-014-1177-1. View

3.
Cullen G, OToole A, Keegan D, Sheahan K, Hyland J, ODonoghue D . Long-term clinical results of ileocecal resection for Crohn's disease. Inflamm Bowel Dis. 2007; 13(11):1369-73. DOI: 10.1002/ibd.20220. View

4.
Gao X, Yang R, Chen M, Xiao Y, He Y, Chen B . Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease. Scand J Gastroenterol. 2012; 47(10):1181-91. DOI: 10.3109/00365521.2012.668931. View

5.
Podolsky D . Inflammatory bowel disease. N Engl J Med. 2002; 347(6):417-29. DOI: 10.1056/NEJMra020831. View